Westside Investment Management Inc. Acquires 116,650 Shares of enVVeno Medical Corporation (NASDAQ:NVNO)

Westside Investment Management Inc. lifted its holdings in shares of enVVeno Medical Corporation (NASDAQ:NVNO - Free Report) by 132.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 205,025 shares of the company's stock after purchasing an additional 116,650 shares during the quarter. Westside Investment Management Inc. owned 1.17% of enVVeno Medical worth $619,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Geode Capital Management LLC boosted its stake in enVVeno Medical by 7.8% in the third quarter. Geode Capital Management LLC now owns 150,676 shares of the company's stock valued at $506,000 after buying an additional 10,902 shares in the last quarter. Fermata Advisors LLC boosted its stake in shares of enVVeno Medical by 18.1% in the 4th quarter. Fermata Advisors LLC now owns 35,706 shares of the company's stock valued at $108,000 after purchasing an additional 5,481 shares in the last quarter. Hohimer Wealth Management LLC bought a new stake in shares of enVVeno Medical during the 3rd quarter valued at approximately $286,000. Maven Securities LTD acquired a new position in enVVeno Medical during the 3rd quarter worth approximately $295,000. Finally, Corsair Capital Management L.P. bought a new position in enVVeno Medical in the 3rd quarter valued at approximately $390,000. Institutional investors own 34.71% of the company's stock.

enVVeno Medical Price Performance

NASDAQ NVNO traded down $0.03 during trading hours on Thursday, reaching $3.49. The company's stock had a trading volume of 66,168 shares, compared to its average volume of 130,233. The stock has a market cap of $61.21 million, a P/E ratio of -2.71 and a beta of 1.21. The firm has a fifty day simple moving average of $3.13 and a 200-day simple moving average of $4.08. enVVeno Medical Corporation has a 52 week low of $2.45 and a 52 week high of $6.97.

enVVeno Medical (NASDAQ:NVNO - Get Free Report) last issued its quarterly earnings data on Thursday, October 31st. The company reported ($0.35) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.33) by ($0.02). On average, research analysts expect that enVVeno Medical Corporation will post -1.3 earnings per share for the current year.

enVVeno Medical Company Profile

enVVeno Medical Corporation Nasdaq: NVNO is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company's lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).